Richard Clegg

Richard Clegg
Richard is a member of our life sciences patent team and has particular experience in the biotechnology and pharmaceutical sectors. He has a diverse patent practise, working closely with clients in the UK, Europe and Singapore to prepare patent applications and prosecute them to grant on a global basis. He also works with many US clients to obtain European patents before the EPO and defend them in EPO opposition/appeal proceedings. Since 2003, Richard has been heavily involved in obtaining European patents for aptamer (SELEX) technology and succeeded in obtaining grant of the very first aptamer patents in Europe. Richard also has considerable involvement with start-up and spin out companies, including transition of patent portfolios from technology transfer into nascent companies. In addition to patent prosecution, this often involves generating and implementing an ongoing freedom to operate strategy for the company and conducting IP due diligence for the purpose of helping the company raise investment. Richard has provided in-house support to some SME clients, spending time in the R&D department to spot inventions and generate new patent applications.

Find me on:

Recent Posts

Morphosis: creating and nurturing biotech start-ups in Singapore

Richard Clegg

Richard Clegg
31 Oct 2018

We understand that early-stage biotech companies do not have it easy. It is a long road from pre-clinical research to bringing a product or treatment to.